The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index; 47 of the 69 sources its claims cite were checked for support.
Abstract
We performed a comparative functional analysis of NPAS3-HAR202 using enhancer reporter assays in transgenic zebrafish and mice. We found that the Homo sapiens HAR202 ortholog failed to drive reporter expression to the zebrafish nervous system, in high contrast to the strong expression displayed by the rest of the vertebrate ortholog sequences tested. Remarkably, the HAR202 ortholog from archaic humans (Neanderthals/Denisovans) also displayed a pan-vertebrate expression pattern, despite the fact that archaic and modern humans have only one nucleotide substitution. Moreover, similar results were found when comparing enhancer activity in transgenic mice, where we observed a loss of activity of the modern human version in the mouse developing brain.
Overview
CoChat Summary
TL;DR
HAR202 is a highly conserved noncoding element in an intron of NPAS3 whose modern human version differs from archaic human sequence by one nucleotide and shows reduced enhancer activity in vivo. The paper links that modern human substitution to loss of forebrain enhancer function and to reduced Npas3 expression in HAR202 knockout mouse forebrain.
Key findings
- HAR202 spans 202 bp in the fifth intron of NPAS3 and shows 7 nucleotide substitutions versus chimpanzee; 4 of those are H. sapiens-specific.
- Modern and archaic human HAR202 differ by 1 nucleotide; the modern human-specific change is a T → A transversion at rs79570848, and the derived A allele is reported as nearly fixed (~96%) in modern humans.
- In transgenic zebrafish, all tested vertebrate HAR202 orthologs except modern human drove EGFP expression in the nervous system; modern human HAR202 drove no detectable expression.
- In transgenic mice, archaic human HAR202 drove reporter expression in forebrain/anterior and posterior brain regions from E11.5 to E14.5, while modern human HAR202 drove expression in hindbrain, spinal cord, eyes, and limbs but not anterior brain structures.
- HAR202 knockout mice were viable and fertile, but at E13.5 showed a substantial decrease of Npas3 mRNA in the forebrain; hindbrain expression was unchanged.
Methods
- Comparative sequence analysis of HAR202 across vertebrates, archaic humans, and modern human populations using UCSC Genome Browser, ClustalW/MEGA X, JASPAR, ENCODE/ROADMAP, and Sprime; polymorphism data came from public population databases including 1000 Genomes.
- Functional enhancer testing in transgenic zebrafish and transgenic mice using reporter constructs carrying HAR202 orthologs from modern human, archaic human, chimpanzee, macaque, mouse, chicken, and zebrafish.
- Generation of HAR202 knockout mice with CRISPR/Cas9, followed by RT-qPCR and in situ hybridization at E13.5 to assess Npas3 expression.
Limitations
- The paper states that evidence for human brain function is indirect: it notes that additional studies are necessary to compare NPAS3 expression in developing human brains carrying different HAR202 alleles.
- It also says the functional roles of the coexisting human HAR202 variants in cognitive function or neurodevelopmental disorders remain unresolved, and that this is speculative rather than established.
- Evident from the text: the human enhancer activity conclusions rely on transgenic animal assays and public genomic datasets, not direct manipulation or measurement in human fetal brain tissue.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
27 Valid · 10 Not valid · 16 Not checked · 66 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In contrast, this interaction was not observed in Hi-C experiments performed in cells neither from adult human dorsolateral prefrontal cortex (Schmitt et al. 2016; supplementary fig. S9, Supplementary Material online) nor from developing human cerebral cortex at mid-gestation (Won et al. 2016; supplementary fig. S10, Supplementary Material online).”
§ The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences > Results > Active Enhancer Epigenetic Marks in Mouse, but not Human, HAR202 During Brain Development To further explore the possible participation of HAR202 as a regulatory element in the developing brain of mice and humans we first analyzed data from the ENCODE consortium in the mouse genome (UCSC Genome Browser mm10; supplementary fig. S7, Supplementary Material online) and found that the annotated region cHMM e7709 predicts a regulatory element based on epigenetic marks typically found in active enhancers, such as H3K4me1 (Heintzman et al. 2009) and H3K27ac (Creyghton et al. 2010), detected in the forebrain, midbrain and hindbrain of E12–E16 mouse embryos (Gorkin et al. 2020). Particularly at E13.5, the stage we compared Npas3 expression in WT and HAR202 KO embryos, mouse HAR202 displays H3K4me1 signatures in all tissues analyzed, and H3K27ac marks in neural tissues, particularly in the hindbrain (supplementary fig. S7, Supplementary Material online). In contrast, NPCs and maturing neurons from human fetal brain tissue (gestational week [GW] 19–20) showed no H3K4me1 or H3K27ac signatures, suggesting that the human HAR202 ortholog does not act as a transcriptional enhancer in the developing human brain (supplementary fig. S8, Supplementary Material online; (Girskis et al. 2021). In addition, single nucleus ATAC-seq experiments performed in developing human brain cells obtained during the first trimester (from 6 to 13 postconceptional weeks [pcw]; Mannens et al. 2024), at mid-gestation (from 6 to 20 pcw; [Nowakowski et al. 2017] and from 12 to 18 pcw [Domcke et al. 2020]), and in the third trimester of gestation (Velmeshev et al. 2023) HAR202 as a chromatin open region precluding its participation as an active NPAS3 enhancer (supplementary figs. S7 and S8, Supplementary Material online). Interestingly, Hi-C data obtained using differentiated mouse neurons led us to detect chromatin interactions between HAR202 and the Npas3 promoter (Bonev et al. 2017; supplementary fig. S8, Supplementary Material online). In contrast, this interaction was not observed in Hi-C experiments performed in cells neither from adult human dorsolateral prefrontal cortex (Schmitt et al. 2016; supplementary fig. S9, Supplementary Material online) nor from developing human cerebral cortex at mid-gestation (Won et al. 2016; supplementary fig. S10, Supplementary Material online). These data support the idea that human HAR202 does not participate as a transcriptional enhancer of NPAS3 in the developing and adult human forebrain.
What the sources say
- Could not verifycites Schmitt et al. 2016 sourceExperimental — accuracy not yet measured
The Results section, “A compendium of chromatin organization maps across 21 human cell and tissue types” (page unavailable), reports Hi-C analysis of human tissues, and the tissue-specific FIREs section mentions cortex data. But searches for HAR202, NPAS3, and dorsolateral prefrontal cortex found no passage assessing whether the HAR202–NPAS3 promoter interaction was observed. The mid-gestation claim is attributed to Won et al., not to this source. (LLM, conf=0.74)
- Supportedcites Won et al. 2016 source
The paper’s Abstract (page not provided) states that Won et al. constructed Hi-C libraries from mid-gestation developing human cerebral cortex, confirming the citation as the source of those experiments. The HAR202–Npas3 non-observation is presented as the citing authors’ reading of their own supplementary figure S10, not as a finding reported by Won et al. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“suggesting that the human HAR202 ortholog does not act as a transcriptional enhancer in the developing human brain (supplementary fig. S8, Supplementary Material online; (Girskis et al. 2021).”
§ The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences > Results > Active Enhancer Epigenetic Marks in Mouse, but not Human, HAR202 During Brain Development To further explore the possible participation of HAR202 as a regulatory element in the developing brain of mice and humans we first analyzed data from the ENCODE consortium in the mouse genome (UCSC Genome Browser mm10; supplementary fig. S7, Supplementary Material online) and found that the annotated region cHMM e7709 predicts a regulatory element based on epigenetic marks typically found in active enhancers, such as H3K4me1 (Heintzman et al. 2009) and H3K27ac (Creyghton et al. 2010), detected in the forebrain, midbrain and hindbrain of E12–E16 mouse embryos (Gorkin et al. 2020). Particularly at E13.5, the stage we compared Npas3 expression in WT and HAR202 KO embryos, mouse HAR202 displays H3K4me1 signatures in all tissues analyzed, and H3K27ac marks in neural tissues, particularly in the hindbrain (supplementary fig. S7, Supplementary Material online). In contrast, NPCs and maturing neurons from human fetal brain tissue (gestational week [GW] 19–20) showed no H3K4me1 or H3K27ac signatures, suggesting that the human HAR202 ortholog does not act as a transcriptional enhancer in the developing human brain (supplementary fig. S8, Supplementary Material online; (Girskis et al. 2021). In addition, single nucleus ATAC-seq experiments performed in developing human brain cells obtained during the first trimester (from 6 to 13 postconceptional weeks [pcw]; Mannens et al. 2024), at mid-gestation (from 6 to 20 pcw; [Nowakowski et al. 2017] and from 12 to 18 pcw [Domcke et al. 2020]), and in the third trimester of gestation (Velmeshev et al. 2023) HAR202 as a chromatin open region precluding its participation as an active NPAS3 enhancer (supplementary figs. S7 and S8, Supplementary Material online). Interestingly, Hi-C data obtained using differentiated mouse neurons led us to detect chromatin interactions between HAR202 and the Npas3 promoter (Bonev et al. 2017; supplementary fig. S8, Supplementary Material online). In contrast, this interaction was not observed in Hi-C experiments performed in cells neither from adult human dorsolateral prefrontal cortex (Schmitt et al. 2016; supplementary fig. S9, Supplementary Material online) nor from developing human cerebral cortex at mid-gestation (Won et al. 2016; supplementary fig. S10, Supplementary Material online). These data support the idea that human HAR202 does not participate as a transcriptional enhancer of NPAS3 in the developing and adult human forebrain.
What the sources say
- Could not verifycites Girskis et al. 2021 sourceExperimental — accuracy not yet measured
The Results discuss enhancer activity across HARs in neural cells and developing human brain tissue, while the Discussion says 11% of HARs lacked evidence of enhancer activity in the cell types analyzed. Searches for HAR202 and its enhancer activity found no passage identifying whether HAR202 is among them, so our copy does not establish the claim about that specific ortholog. (LLM, conf=0.72)
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Interestingly, Hi-C data obtained using differentiated mouse neurons led us to detect chromatin interactions between HAR202 and the Npas3 promoter (Bonev et al. 2017; supplementary fig. S8, Supplementary Material online).”
§ The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences > Results > Active Enhancer Epigenetic Marks in Mouse, but not Human, HAR202 During Brain Development To further explore the possible participation of HAR202 as a regulatory element in the developing brain of mice and humans we first analyzed data from the ENCODE consortium in the mouse genome (UCSC Genome Browser mm10; supplementary fig. S7, Supplementary Material online) and found that the annotated region cHMM e7709 predicts a regulatory element based on epigenetic marks typically found in active enhancers, such as H3K4me1 (Heintzman et al. 2009) and H3K27ac (Creyghton et al. 2010), detected in the forebrain, midbrain and hindbrain of E12–E16 mouse embryos (Gorkin et al. 2020). Particularly at E13.5, the stage we compared Npas3 expression in WT and HAR202 KO embryos, mouse HAR202 displays H3K4me1 signatures in all tissues analyzed, and H3K27ac marks in neural tissues, particularly in the hindbrain (supplementary fig. S7, Supplementary Material online). In contrast, NPCs and maturing neurons from human fetal brain tissue (gestational week [GW] 19–20) showed no H3K4me1 or H3K27ac signatures, suggesting that the human HAR202 ortholog does not act as a transcriptional enhancer in the developing human brain (supplementary fig. S8, Supplementary Material online; (Girskis et al. 2021). In addition, single nucleus ATAC-seq experiments performed in developing human brain cells obtained during the first trimester (from 6 to 13 postconceptional weeks [pcw]; Mannens et al. 2024), at mid-gestation (from 6 to 20 pcw; [Nowakowski et al. 2017] and from 12 to 18 pcw [Domcke et al. 2020]), and in the third trimester of gestation (Velmeshev et al. 2023) HAR202 as a chromatin open region precluding its participation as an active NPAS3 enhancer (supplementary figs. S7 and S8, Supplementary Material online). Interestingly, Hi-C data obtained using differentiated mouse neurons led us to detect chromatin interactions between HAR202 and the Npas3 promoter (Bonev et al. 2017; supplementary fig. S8, Supplementary Material online). In contrast, this interaction was not observed in Hi-C experiments performed in cells neither from adult human dorsolateral prefrontal cortex (Schmitt et al. 2016; supplementary fig. S9, Supplementary Material online) nor from developing human cerebral cortex at mid-gestation (Won et al. 2016; supplementary fig. S10, Supplementary Material online). These data support the idea that human HAR202 does not participate as a transcriptional enhancer of NPAS3 in the developing and adult human forebrain.
What the sources say
- Supportedcites Bonev et al. 2017 source
The Figure S1 caption (Results, page unavailable) identifies Hi-C samples generated from in-vitro-differentiated mouse neurons, and the Key Resources Table (page unavailable) lists the study’s raw Hi-C data. The citing authors say that their own analysis of those data detected the HAR202–Npas3 interaction; they do not attribute that specific detection to Bonev et al. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We analyzed chromosome 14 in every population from this database and found that the HAR202 region shows signatures of introgression in populations from East Asian (Fig. 2b; supplementary table S1, Supplementary Material online and supplementary fig. S2, Supplementary Material online).”
§ The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences > Results > The HAR202 Region Shows Signatures of Introgression From Archaic Humans The fact that some particular non-African populations display low levels of the ancestral variant T at rs79570848 which is carried by archaic humans suggests that this variant could have been introgressed into these populations through admixture between archaic and modern humans. Increasing evidence indicates that admixture between archaic and modern humans occurred since varying amounts of archaic DNA have been detected in our genomes. In particular, non-African populations show 1% to 2% of Neanderthal ancestry in their genomes (Green et al. 2010; Prüfer et al. 2014) and Melanesians and East Asians display 3% and 0.2%, respectively, from Denisovans ancestry (Green et al. 2010; Meyer et al. 2012; Prüfer et al. 2014). It has been shown that Papuans and Indigenous Australians carry the largest amount of Denisovan introgression (∼1% to 5%), followed by East and South Asians (∼0.06% to 0.5%), and Indigenous Americans (∼0.05% to 0.4%) (Reich et al. 2010; Racimo et al. 2015; Mallick et al. 2016; Sankararaman et al. 2016; Browning et al. 2018). To search for signatures of introgression in the human chromosome 14 genomic region bearing the HAR202 sequence, we take advantage of the Sprime method developed by Browning and cols (Browning et al. 2018) which is based on linkage disequilibrium and allows finding introgressed regions that are less closely related to the sequenced archaic genomes. Using this method, the authors generated a database of introgressed regions in each non-African population from the 1000 Genomes Project (Browning 2018). We analyzed chromosome 14 in every population from this database and found that the HAR202 region shows signatures of introgression in populations from East Asian (Fig. 2b; supplementary table S1, Supplementary Material online and supplementary fig. S2, Supplementary Material online).
What the sources say
- Partly supportedcites Browning et al. 2018 sourceExperimental — accuracy not yet measured
The Results section, “Detection of putative archaic introgression in human populations” (page unavailable), reports introgression in East Asian populations. But neither that passage nor the passages retrieved for “HAR202” identify introgression at HAR202 specifically; the chromosome 14 region discussed in “Signals of positive selection” is the IGH locus. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In contrast, NPCs and maturing neurons from human fetal brain tissue (gestational week [GW] 19–20) showed no H3K4me1 or H3K27ac signatures, suggesting that the human HAR202 ortholog does not act as a transcriptional enhancer in the developing human brain (supplementary fig. S8, Supplementary Material online; (Girskis et al. 2021).”
§ The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences > Results > Active Enhancer Epigenetic Marks in Mouse, but not Human, HAR202 During Brain Development To further explore the possible participation of HAR202 as a regulatory element in the developing brain of mice and humans we first analyzed data from the ENCODE consortium in the mouse genome (UCSC Genome Browser mm10; supplementary fig. S7, Supplementary Material online) and found that the annotated region cHMM e7709 predicts a regulatory element based on epigenetic marks typically found in active enhancers, such as H3K4me1 (Heintzman et al. 2009) and H3K27ac (Creyghton et al. 2010), detected in the forebrain, midbrain and hindbrain of E12–E16 mouse embryos (Gorkin et al. 2020). Particularly at E13.5, the stage we compared Npas3 expression in WT and HAR202 KO embryos, mouse HAR202 displays H3K4me1 signatures in all tissues analyzed, and H3K27ac marks in neural tissues, particularly in the hindbrain (supplementary fig. S7, Supplementary Material online). In contrast, NPCs and maturing neurons from human fetal brain tissue (gestational week [GW] 19–20) showed no H3K4me1 or H3K27ac signatures, suggesting that the human HAR202 ortholog does not act as a transcriptional enhancer in the developing human brain (supplementary fig. S8, Supplementary Material online; (Girskis et al. 2021). In addition, single nucleus ATAC-seq experiments performed in developing human brain cells obtained during the first trimester (from 6 to 13 postconceptional weeks [pcw]; Mannens et al. 2024), at mid-gestation (from 6 to 20 pcw; [Nowakowski et al. 2017] and from 12 to 18 pcw [Domcke et al. 2020]), and in the third trimester of gestation (Velmeshev et al. 2023) HAR202 as a chromatin open region precluding its participation as an active NPAS3 enhancer (supplementary figs. S7 and S8, Supplementary Material online). Interestingly, Hi-C data obtained using differentiated mouse neurons led us to detect chromatin interactions between HAR202 and the Npas3 promoter (Bonev et al. 2017; supplementary fig. S8, Supplementary Material online). In contrast, this interaction was not observed in Hi-C experiments performed in cells neither from adult human dorsolateral prefrontal cortex (Schmitt et al. 2016; supplementary fig. S9, Supplementary Material online) nor from developing human cerebral cortex at mid-gestation (Won et al. 2016; supplementary fig. S10, Supplementary Material online). These data support the idea that human HAR202 does not participate as a transcriptional enhancer of NPAS3 in the developing and adult human forebrain.
What the sources say
- Partly supportedcites Girskis et al. 2021 sourceExperimental — accuracy not yet measured
The Results section, “HARs demonstrate in vivo enhancer features during human brain development” (page unavailable), confirms that the authors tested H3K4me1 and H3K27ac in NPCs and maturing neurons from GW 19–20 fetal brain tissue. It does not report that the HAR202 ortholog lacked those marks; instead, it reports enhancer-associated marks at 504 HARs. The HAR202-specific absence of signatures is therefore not established by our copy. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
60 more claims · 11 with their cited sources checked
Create a free account to see all 119 claims and every source verdict.
- Probably not a substantial claim. 40
- It may state two separate claims as one. 23
Citations
Cites
A draft sequence of the Neandertal genome
Green, R. E., Krause, J., Briggs, A. W., Maricic, T., Stenzel, U., Kircher, M., Patterson, N., Li, H., Zhai, W., Fritz, M. H.-Y., et al. (2010) · Science · doi:10.1126/science.1188021 · Cited by 4,318 · cited 1×
“In particular, non-African populations show 1% to 2% of Neanderthal ancestry in their genomes (Green et al. 2010; Prüfer et al. 2014) and Melanesians and East Asians display 3% and 0.2%, respectively, from Denisovans ancestry (Green et al. 2010; Meyer et al. 2012; Prüfer et al. 2014).”
BackgroundInfluentialHistone H3K27ac separates active from poised enhancers and predicts developmental state
Creyghton, M. P., Cheng, A. W., Welstead, G. G., Kooistra, T., Carey, B. W., Steine, E. J., Hanna, J., Lodato, M. A., Frampton, G. M., Sharp, P. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016071107 · Cited by 4,302 · cited 3×
“S7, Supplementary Material on-line) and found that the annotated region cHMM e7709 predicts a regulatory element based on epigenetic marks typically found in active enhancers, such as H3K4me1 (Heintzman et al. 2009) and H3K27ac (Creyghton et al. 2010), detected in the forebrain, midbrain and hindbrain of E12–E16 mouse…”
BackgroundHistone modifications at human enhancers reflect global cell-type-specific gene expression
Heintzman, N. D., Hon, G. C., Hawkins, R. D., Kheradpour, P., Stark, A., Harp, L. F., Ye, Z., Lee, L. K., Stuart, R. K., Ching, C. W., et al. (2009) · Nature · doi:10.1038/nature07829 · Cited by 2,533 · cited 3×
“S7, Supplementary Material on-line) and found that the annotated region cHMM e7709 predicts a regulatory element based on epigenetic marks typically found in active enhancers, such as H3K4me1 (Heintzman et al. 2009) and H3K27ac (Creyghton et al. 2010), detected in the forebrain, midbrain and hindbrain of E12–E16 mouse…”
BackgroundThe complete genome sequence of a Neanderthal from the Altai Mountains
Prüfer, K., Racimo, F., Patterson, N., Jay, F., Sankararaman, S., Sawyer, S., Heinze, A., Renaud, G., Sudmant, P. H., de Filippo, C., et al. (2014) · Nature · doi:10.1038/nature12886 · Cited by 2,254
Genetic history of an archaic hominin group from Denisova Cave in Siberia
Reich, D., Green, R. E., Kircher, M., Krause, J., Patterson, N., Durand, E. Y., Viola, B., Briggs, A. W., Stenzel, U., Johnson, P. L. F., et al. (2010) · Nature · doi:10.1038/nature09710 · Cited by 1,991 · cited 1×
“(Reich et al. 2010; Racimo et al. 2015; Mallick et al. 2016; Sankararaman et al. 2016; Browning et al. 2018).”
A high-coverage genome sequence from an archaic denisovan individual
Meyer, M., Kircher, M., Gansauge, M.-T., Li, H., Racimo, F., Mallick, S., Schraiber, J. G., Jay, F., Prüfer, K., de Filippo, C., et al. (2012) · Science · doi:10.1126/science.1224344 · Cited by 1,967 · cited 10×
“…Ancient Genome Browser (http://cdna.eva.mpg.de/ neandertal/Vindija/VCF/) containing the sequences of Denisova Cave in the Altai Mountains and Vindija Cave specimens (Prüfer et al. 2014, 2017) and from the Denisovan sequence UCSC track (Assembly: Human Feb. 2009 (GRCh37/hg19) (Meyer et al. 2012).”
BackgroundMethodInfluentialJASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles
Castro-Mondragon, J. A., Riudavets-Puig, R., Rauluseviciute, I., Berhanu Lemma, R., Turchi, L., Blanc-Mathieu, R., Lucas, J., Boddie, P., Khan, A., Manosalva Pérez, N., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkab1113 · Cited by 1,935
The NHGRI-EBI GWAS Catalog: knowledgebase and deposition resource
Sollis, E., Mosaku, A., Abid, A., Buniello, A., Cerezo, M., Gil, L., Groza, T., Güneş, O., Hall, P., Hayhurst, J., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1010 · Cited by 1,641
The Simons Genome Diversity Project: 300 genomes from 142 diverse populations
Mallick, S., Li, H., Lipson, M., Mathieson, I., Gymrek, M., Racimo, F., Zhao, M., Chennagiri, N., Nordenfelt, S., Tandon, A., et al. (2016) · Nature · doi:10.1038/nature18964 · Cited by 1,584 · cited 1×
“(Reich et al. 2010; Racimo et al. 2015; Mallick et al. 2016; Sankararaman et al. 2016; Browning et al. 2018).”
Multiscale 3D Genome Rewiring during Mouse Neural Development
Bonev, B., Mendelson Cohen, N., Szabo, Q., Fritsch, L., Papadopoulos, G. L., Lubling, Y., Xu, X., Lv, X., Hugnot, J.-P., Tanay, A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.043 · Cited by 1,338 · cited 1×
“In contrast, NPCs and maturing neurons from human fetal brain tissue (gestational week [GW] Interestingly, Hi-C data obtained using differentiated mouse neurons led us to detect chromatin interactions be-tween HAR202 and the Npas3 promoter (Bonev et al. 2017; supplementary fig.”
Background
Cited by
Reduced Adult Neurogenesis in Humans Results From a Tradeoff Rather Than Direct Negative Selection
Morizet, D., & Bally‐Cuif, L. (2025) · BioEssays · doi:10.1002/bies.70041 · Cited by 3
Comparative genomics sheds light on mammalian and avian gene regulation and phenotypic evolution
Trigila, A. P., Beati, P., Montini, D., Jovicic, C., de la Vega, P., & Franchini, L. F. (2025) · Nature Communications · doi:10.1038/s41467-025-64134-2 · Cited by 3
Self-citationHuman Accelerated Regions: Functional Studies and Methodological Approaches (A Review)
Knyazeva, A. S., & Шнайдер, Т. А. (2026) · Cell and Tissue Biology · doi:10.1134/s1990519x25600784 · Cited by 1
“…cerebral organoids (Liu et al., 2025), facilitating the connection between regulatory changes and their effects, including not only transcriptional (Dutrow et al., 2022; Caporale et al., 2024), but also phenotypic outcomes (Boyd et al., 2015; Cui et al., 2025; Liu et al., 2025; Tan et al., 2025).”
InfluentialIuditskaia, M. E., Semina, E. V., Pankratova, E. D., Kurinnaia, O. S., Guldan, E. V., Abasov, E. H., Iourov, I. Y., & Chaika, Y. A. (2026) · Scientific Reports · doi:10.1038/s41598-026-76092-w
“Moreover, many HARs act as enhancers during embryonic neurodevelopment [20,21], and in brain structures that exhibit human-specific morphological features [22,23].”
Iuditskaia, M. E., Semina, E. V., Pankratova, E. D., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8988912/v1
Metadata
- Authors
- Caporale, A. L., Cinalli, A. R., Rubinstein, M., & Franchini, L. F.
- Affiliations
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Corresponding author
- Franchini, Lucía F
- Venue
- Molecular Biology and Evolution
- Publisher
- Oxford University Press (OUP)
- Published
- 2024-09-07
- Volume
- 41
- Issue
- 10
- ISSN
- 0737-4038 (ISSN-L)
- 1537-1719
- PMC
- PMC11461159
- OpenAlex
- W4402336721
- Semantic Scholar
- adc0b37393b35783968586614ceec4b116ce254d
- Cited by
- 7
- References
- 80
- Citations by year
- 2026: 5 · 2025: 2
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecular Biology and Evolution (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Conicet (publishedVersion, cc-by-nc-sa)
- Funders
- Agencia Nacional de Promoción Científica y Tecnológica
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Chromosomal and Genetic Variations
- Keywords
- human accelerated regions, NPAS3, enhancer evolution, forebrain development, brain development, archaic humans, Neanderthals, Denisovans, transgenic zebrafish, transgenic mice, human cognitive evolution, transcriptional regulation
- MeSH terms
- Animals, Enhancer Elements, Genetic, Humans, Mice, Transgenic, Nerve Tissue Proteins, Zebrafish, Prosencephalon, Gene Expression Regulation, Developmental, Evolution, Molecular, Mice, Basic Helix-Loop-Helix Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences. https://app.cochat.ai/papers/10.1093/molbev/msae186
- The paper
- Caporale, A. L., Cinalli, A. R., Rubinstein, M., & Franchini, L. F. (2024). The Human Accelerated Region HAR202 Controls NPAS3 Expression in the Developing Forebrain Displaying Differential Enhancer Activity Between Modern and Archaic Human Sequences. Molecular Biology and Evolution. https://doi.org/10.1093/molbev/msae186
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.